Goods & Services

Active chemical ingredients for manufacturing pharmaceuticals for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Chemicals for manufacturing pharmaceuticals, food supplements and dietary preparations for use in pain treatment in humans; Chemical substances used as food ingredients for use in pain treatment in humans; Plant extracts other than essential oils, for use in the following fields: The manufacture of pharmaceuticals and food supplements for pain treatment in humans. pain treatment pharmaceutical products; Pharmaceutical preparations and substances for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Plant and herb extracts for medical and pharmaceutical uses and for the preparation of food supplements for use in pain treatment in humans.

Goods & Services

Active chemical ingredients for manufacturing pharmaceuticals for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Chemicals for manufacturing pharmaceuticals, food supplements and dietary preparations for use in pain treatment in humans; Chemical substances used as food ingredients for use in pain treatment in humans; Plant extracts other than essential oils, for use in the following fields: The manufacture of pharmaceuticals and food supplements for pain treatment in humans. pain treatment pharmaceutical products; Pharmaceutical preparations and substances for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Plant and herb extracts for medical and pharmaceutical uses and for the preparation of food supplements for use in pain treatment in humans.

Abstract

Crithmum maritimumCrithmum maritimum, stabilised with a lipophilising agent selected from hydrogenated vegetable oils, fatty alcohols, fatty acids, fatty acid monoglycerides, fatty acid diglycerides, fatty acid triglycerides, polyoxylglycerides and waxes. The extracts according to the invention are useful as active ingredients of pharmaceutical compositions or dietary supplements for human or veterinary use, which are useful for the treatment and/or in the prevention of disorders of the gastrointestinal system.

IPC Classes  ?

• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Goods & Services

Active chemical ingredients for manufacturing pharmaceuticals for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Chemicals for manufacturing pharmaceuticals, food supplements and dietary preparations for use in pain treatment in humans; Chemical substances used as food ingredients for use in pain treatment in humans; Plant extracts other than essential oils, for use in the following fields: The manufacture of pharmaceuticals and food supplements for pain treatment in humans. pain treatment pharmaceutical products; Pharmaceutical preparations and substances for pain treatment; Food supplements and dietary preparations for use in pain treatment in humans; Plant and herb extracts for medical and pharmaceutical uses and for the preparation of food supplements for use in pain treatment in humans.

Goods & Services

Cosmetics containing botanical extracts. Pharmaceutical products containing extracts from medicinal plants for the treatment of cardiovascular system diseases, central nervous system and locomotor apparatus diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases and eye and ocular adnexa diseases; dietary and nutritional supplements. Scientific research in the fields of chemicals, pharmaceuticals, hygienic and beauty care.

Goods & Services

Botanical extracts containing quercetin and quercetin derivatives for pharmaceutical and medical use; pharmaceutical products and nutritional supplements containing quercetin for the treatment of cardiovascular system diseases, urinary system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, central nervous system diseases, locomotor apparatus diseases, skin diseases and for the treatment of painful conditions.

Goods & Services

Botanical extracts containing quercetin and quercetin derivatives for pharmaceutical and medical use; pharmaceutical products and nutritional supplements containing quercetin for the treatment of cardiovascular system diseases, urinary system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, central nervous system diseases, locomotor apparatus diseases, skin diseases and for the treatment of painful conditions.

Goods & Services

Active chemical ingredients for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemicals for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical substances for use as food ingredients for human and animal use; Plant extracts, other than essential oils, for use in the manufacture of pharmaceuticals and dietary supplements; Plant extracts, other than essential oils, for use in the manufacture of cosmetics. Herbal extracts for cosmetic purposes; Cosmetic products. Pharmaceuticals; Veterinary preparations; pharmaceutical and veterinary preparations and substances; dietary supplements and dietetic preparations for human and animal use; plant and herb extracts for medicinal, pharmaceutical and veterinary use and for the preparation of dietary supplements for human and animal use.

Goods & Services

Chemicals derived from botanical extracts, namely from cranberry and from plants of the genus vaccinium belonging to the family Ericaceae, for use in the preparation of pharmaceutical products, nutraceuticals, cosmetic products and foodstuff. Extracts from medicinal plants, namely from cranberry and from plants of the genus vaccinium belonging to the family Ericaceae, for pharmaceutical, nutraceutical and medical use, namely for the treatment of cardiovascular system diseases, for the treatment of urinary system diseases, for the treatment of cystitis, for the treatment of immune and endocrine system diseases and for the treatment of chronic inflammatory conditions; pharmaceutical products and nutraceuticals for the treatment of cardiovascular system diseases, for the treatment of urinary system diseases, for the treatment of cystitis, for the treatment of immune and endocrine system diseases and for the treatment of chronic inflammatory conditions.

Abstract

The present invention relates to compositions comprising an American cranberry extract combined with phospholipids, and the use thereof in the prevention and treatment of urinary tract infections. The invention also relates to processes for the preparation of said compositions, and formulations for oral administration comprising said compositions.

IPC Classes  ?

• A61K 36/45 - Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
• A61K 31/685 - Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
• A61P 13/02 - Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
• A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

The invention relates to an amorphous solid dispersion comprising ferric maltol and a polymer, and the preparation process thereof.

IPC Classes  ?

• A61K 33/26 - IronCompounds thereof
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Goods & Services

Chemicals derived from botanical extracts, namely from cranberry and from plants of the genus vaccinium belonging to the family Ericaceae, for use in the preparation of pharmaceutical products, nutraceuticals, cosmetic products and foodstuff. Extracts from medicinal plants, namely from cranberry and from plants of the genus vaccinium belonging to the family Ericaceae, for pharmaceutical, nutraceutical and medical use, namely for the treatment of cardiovascular system diseases, for the treatment of urinary system diseases, for the treatment of cystitis, for the treatment of immune and endocrine system diseases and for the treatment of chronic inflammatory conditions; pharmaceutical products and nutraceuticals for the treatment of cardiovascular system diseases, for the treatment of urinary system diseases, for the treatment of cystitis, for the treatment of immune and endocrine system diseases and for the treatment of chronic inflammatory conditions.

Goods & Services

Chemicals derived from botanical extracts for use in the manufacture of pharmaceutical products, cosmetic products, nutritional supplements and foodstuffs. Cosmetics containing botanical extracts. Pharmaceutical products containing extracts from medicinal plants for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine systems diseases, for the treatment of chronic inflammatory diseases and for the treatment of eye and ocular adnexa diseases.

Abstract

The invention relates to a process for the preparation of an intermediate useful for the synthesis of voclosporin, an immunosuppressant active ingredient inhibitor of calcineurin.

IPC Classes  ?

• C07K 7/64 - Cyclic peptides containing only normal peptide links

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients. Cosmetics. Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medicinal use, pharmaceutical purposes and for manufacture of food supplements. Custom manufacture of pharmaceuticals.

Goods & Services

Active chemical ingredients for the production of dietary supplements and dietetic preparations; chemical preparations for the production of dietary supplements and dietetic preparations. Dietary supplements and dietetic preparations; plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

(1) Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients. (2) Cosmetics. (3) Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medicinal use, pharmaceutical purposes and for manufacture of food supplements. (1) Custom manufacture of pharmaceuticals.

Goods & Services

Active chemical ingredients for use in the manufacture of dietary supplements and dietetic preparations adapted for medical purposes; chemical preparations for use in the manufacture of dietary supplements and dietetic preparations Dietary supplements and dietetic preparations adapted for medical purposes; plant extracts and herb extracts used as dietary supplements and as dietetic preparations adapted for medical purposes

Goods & Services

Active chemical ingredients for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemicals for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical substances for use as food ingredients for human and animal use. Pharmaceuticals; veterinary preparations; pharmaceutical and veterinary preparations and substances; dietary supplements and dietetic preparations for human and animal use; plant and herb extracts for medicinal, pharmaceutical and veterinary use and for the preparation of dietary supplements for human and animal use.

Goods & Services

Active chemical ingredients for producing the following goods, pharmaceuticals, veterinary prepartions, food supplements and dietetic preparations, for humans and for animal use; chemicals for the manufacture of the following goods, pharmaceuticals, veterinary prepartions, food supplements and dietetic preparations, for humans and for animal use; chemical substances for use as food ingredients, for humans and for animal use. Pharmaceuticals; veterinary preparations; pharmaceutical and veterinary preparations and substances; food supplements and preparations for dietary use, all for human use and for animal use; plant and herbal extracts for medicinal, pharmaceutical and veterinary use and plant and herb extracts for the preparation of dietary supplements, all for human use and for animal use.

Abstract

The present invention relates to a composition comprising cannabidiol and at least two excipients, wherein at least one excipient is a lipid excipient and wherein at least one excipient is a hydrophilic excipient, and wherein the lipid excipient is present in an amount equal to or lower than 20% of the total weight of the composition; the invention also relates to the preparation process of the composition and to pharmaceutical or nutraceutical formulations containing it.

IPC Classes  ?

• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
• A61K 9/10 - DispersionsEmulsions

Goods & Services

Active chemical ingredients in the nature of additives for use in the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemicals for use in the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical substances for use as food ingredients for human and animal use Pharmaceuticals for the treatment of pain and inflammation; veterinary preparations for the treatment of pain and inflammation; pharmaceutical and veterinary preparations and substances f o r the treatment of pain and inflammation; dietary supplements and dietetic preparations adapted for medical purposes for human and animal use; plant and herb extracts, other than essential oils, for medicinal, pharmaceutical and veterinary purposes and for the preparation of dietary supplements for human and animal use for the treatment of pain and inflammation

Goods & Services

Active chemical ingredients for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemicals for the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemical substances for use as food ingredients for human and animal use. Pharmaceuticals; Veterinary preparations; Pharmaceutical and veterinary preparations and substances; Food supplements and Preparations for dietary use, all for human use and For animal use; Plant and herbal extracts for medicinal, pharmaceutical and veterinary use and Plant and herb extracts for the preparation of dietary supplements, all for human use and For animal use.

Goods & Services

Scientific research in the chemical, pharmaceutical, hygienic and beauty care fields.

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients. Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

Active chemical ingredients for production of foodstuffs, active chemical ingredients for the production of dietetic preparations; chemical preparations for the production of foodstuffs, chemicals for the production of dietetic preparations. Dietary supplements and dietetic preparations; plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

Active chemical ingredients in the nature of additives for use in the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use; chemicals for use in the production of pharmaceuticals, veterinary products, dietary supplements and dietetic preparations for human and animal use for the treatment of pain and inflammation; chemical substances for use as food ingredients for human and animal use Pharmaceuticals for the treatment of pain and inflammation; veterinary preparations for the treatment of pain and inflammation; pharmaceutical and veterinary preparations and substances for the treatment of pain and inflammation; dietary supplements and dietetic preparations adapted for medical purposes for human and animal use for the treatment of pain and inflammation; plant and herb extracts, other than essential oils, for medicinal, pharmaceutical and veterinary purposes and for the preparation of dietary supplements for human and animal use for the treatment of pain and inflammation

Abstract

Disclosed are powder solid compositions including a hydroalcoholic extract of Bergamot fruit (Citrus aurantium var. bergamia) and at least one phospholipid. Also disclosed is a process for the preparation of the compositions. The compositions are useful for the prevention and/or treatment of dysmetabolic syndromes, dyslipidemias and type 2 diabetes.

IPC Classes  ?

• A61K 36/752 - Citrus, e.g. lime, orange or lemon
• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
• A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
• A61P 3/06 - Antihyperlipidemics
• A61K 9/14 - Particulate form, e.g. powders
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
• A61K 9/20 - Pills, lozenges or tablets
• A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
• A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin

Goods & Services

Scientific research services for others in the field of chemical and pharmaceutical products.

Goods & Services

(1) Scientific research in the chemical, pharmaceutical, hygienic and beauty care fields.

Goods & Services

Scientific research services for others in the chemical, pharmaceutical, hygienic and beauty care fields

Goods & Services

Scientific research in the chemical, pharmaceutical, hygienic and beauty care fields.

Goods & Services

Medicinal plant extracts for pharmaceutical and medical use, namely, for the treatment of metabolic system diseases such as hyperlipidaemia and hypercholesterolaemia

Goods & Services

(1) Active chemical ingredients for production of foodstuffs, active chemical ingredients for the production of dietetic preparations; chemical preparations for the production of foodstuffs, chemicals for the production of dietetic preparations. (2) Dietary supplements and dietetic preparations; plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

Active chemical ingredients in the nature of additives for use in the production of foodstuffs, active chemical ingredients for use in the production of dietetic preparations; chemical preparations in the nature of additives for use in the production of foodstuffs, chemicals for use in the production of dietetic preparations Dietary supplements and dietetic preparations; plant extracts and herb extracts used as dietary supplements and as dietetic preparations adapted for medical purposes

Goods & Services

Active chemical ingredients for production of foodstuffs, Active chemical ingredients for the production of dietetic preparations; Chemical preparations for the production of foodstuffs, Chemicals for the production of dietetic preparations. Dietary supplements and dietetic preparations; Plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Abstract

The invention relates to a process for the preparation of Melphalan (4-[bis(2-chloroethyl)amino]-L-phenylalanine of formula (I) 2 group. The invention also provides novel intermediates useful for the preparation of Melphalan.

IPC Classes  ?

• C07C 227/20 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino acids or derivatives thereof, e.g. hydrolysis of carbamates

Goods & Services

(1) Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients. (2) Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements

Abstract

Compositions comprising a solid dispersion of quercetin are useful in the treatment and/or prevention of ocular affections.

IPC Classes  ?

• A61K 9/20 - Pills, lozenges or tablets
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61K 31/00 - Medicinal preparations containing organic active ingredients
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system

Abstract

Compositions comprising a solid dispersion of quercetin are useful in the treatment and/or prevention of ocular affections

IPC Classes  ?

• A61K 9/20 - Pills, lozenges or tablets
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

The invention relates to a process for the preparation of colchicine 1 from colchicoside 2 which comprises enzymatic conversion of colchicoside 2 to 3-O-demethylcolchicine 3, wherein the enzyme used is a cellulase. According to another aspect of the invention, 3-O-demethylcolchicine 3 can be converted to colchicine 1 using an alkylating agent. The invention also relates to a process or enriching the colchicine 1 content of extracts from plants belonging to the Colchicaceae family containing colchicine 1, colchicoside 2 and 3-(9-demethyl colchicine 3, which comprises conversion by means of a colchicoside 2 cellulase to 3-O-demethylcolchicine 3, followed by conversion of 3-O-demethylcolchicine 3 to colchicine 1 using an alkylating agent.

IPC Classes  ?

• C12P 15/00 - Preparation of compounds containing at least three condensed carbocyclic rings
• C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
• C07C 233/32 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring

Goods & Services

Chemicals derived from botanical extracts for use in the manufacture of pharmaceuticals cosmetics, nutritional supplements and foodstuffs, expressly excluding combinations of mineral oligoelements and lithotherapeutic minerals

Goods & Services

Active chemical ingredients for production of foodstuffs, Active chemical ingredients for the production of dietetic preparations; Chemical preparations for the production of foodstuffs, Chemicals for the production of dietetic preparations. Dietary supplements and dietetic preparations; Plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

Instructional and training services. Provision of scientific information. Providing medical information.

Goods & Services

Instructional and training services. Provision of scientific information. Providing medical information.

Abstract

Disclosed is a process for the purification of staurosporine (1), which comprises salification of staurosporine (1) (Formula (1)) by treatment with a mineral acid to give a precipitated salt, isolation of the staurosporine (1) precipitated salt, treatment of the staurosporine (1) isolated salt with an organic base, and isolation of staurosporine (1). Also disclosed are novel polymorphic forms of the mono- and bis-hydrochloride salts of staurosporine (1). Disclosed is a process for the purification of staurosporine (1), which comprises salification of staurosporine (1) (Formula (1)) by treatment with a mineral acid to give a precipitated salt, isolation of the staurosporine (1) precipitated salt, treatment of the staurosporine (1) isolated salt with an organic base, and isolation of staurosporine (1). Also disclosed are novel polymorphic forms of the mono- and bis-hydrochloride salts of staurosporine (1).

IPC Classes  ?

• C07D 498/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical substances for use as food ingredients. Pharmaceuticals; Pharmaceutical preparations and substances; Dietary supplements and dietetic preparations; Plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Abstract

Disclosed is a process for the preparation of taxanes esterified with octadecanedioic acid which comprises reacting a taxane with an octadecanedioic acid protected in one of the two carboxyl groups and protected with a group removable by catalysis with transition metals.

IPC Classes  ?

• C07D 305/14 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
• C07C 67/03 - Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
• C07C 69/34 - Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom

Abstract

2 group. The invention also provides novel intermediates useful for the preparation of Melphalan.

IPC Classes  ?

• C07C 227/20 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino acids or derivatives thereof, e.g. hydrolysis of carbamates

Abstract

Disclosed are compositions comprising grape seed extracts, in particular extracts with a proanthocyanidin content exceeding 95% by weight and a catechin and epicatechin content ≥5% and ≤15% by weight, which are useful to prevent or reduce the perception of stress symptoms, in particular the perception of stress among the male population.

IPC Classes  ?

• A61K 36/87 - Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
• A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
• A61P 25/22 - Anxiolytics
• A61K 9/20 - Pills, lozenges or tablets
• A61K 9/28 - DrageesCoated pills or tablets

Goods & Services

Active chemical ingredients for producing the following goods: Pharmaceuticals, veterinary prepartions, Food supplements and Dietetic preparations, for humans and For animal use; Chemicals for the manufacture of the following goods: Pharmaceuticals, veterinary prepartions, Food supplements and Dietetic preparations, for humans and For animal use; Chemical substances for use as food ingredients, for humans and For animal use. Pharmaceuticals; Veterinary preparations; Pharmaceutical and veterinary preparations and substances; Food supplements and Preparations for dietary use, all for human use and For animal use; Plant and herbal extracts for medicinal, pharmaceutical and veterinary use and Plant and herb extracts for the preparation of dietary supplements, all for human use and For animal use.

Abstract

The invention relates to an amorphous solid dispersion comprising ferric maltol and a polymer, and the preparation process thereof.

IPC Classes  ?

• A61K 9/14 - Particulate form, e.g. powders

Abstract

The invention relates to an amorphous solid dispersion comprising ferric maltol and a polymer, and the preparation process thereof.

IPC Classes  ?

• A61K 9/14 - Particulate form, e.g. powders

Goods & Services

Active chemical ingredients for producing the following goods: Pharmaceuticals, veterinary prepartions, Food supplements and Dietetic preparations, for humans and For animal use; Chemicals for the manufacture of the following goods: Pharmaceuticals, veterinary prepartions, Food supplements and Dietetic preparations, for humans and For animal use; Chemical substances for use as food ingredients, for humans and For animal use. Pharmaceuticals; Veterinary preparations; Pharmaceutical and veterinary preparations and substances; Food supplements and Preparations for dietary use, all for human use and For animal use; Plant and herbal extracts for medicinal, pharmaceutical and veterinary use and Plant and herb extracts for the preparation of dietary supplements, all for human use and For animal use.

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients; plant and herb extracts for use in the manufacture of food supplements. Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for use as food supplements.

Abstract

The present invention relates to solid dispersions comprising a salt of ursolic acid with an alkali metal and a phospholipid and to oral dosage formulations containing them. The invention also relates to processes for preparing the solid dispersions and to the use of the solid dispersions and formulations for the prevention and/or treatment of a variety of pathological conditions in which hepatoprotective, antioxidant, anti-inflammatory, antiviral and cytotoxic activities are desired.

IPC Classes  ?

• A61K 31/19 - Carboxylic acids, e.g. valproic acid
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations. Cosmetics. Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

(1) Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations. (2) Cosmetics. (3) Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations Cosmetics Pharmaceuticals for the treatment of skin, nail and hair conditions and diseases; pharmaceutical preparations and substances for the treatment of skin, nail and hair conditions and diseases; dietary supplements and dietetic preparations adapted for medical purposes; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients; plant and herb extracts for use in the manufacture of food supplements Pharmaceuticals for the treatment of gastrointestinal diseases, osteoarthritis, bone and joints diseases, pain, respiratory diseases, age-related diseases and amelioration of metabolism; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, osteoarthritis, bone and joints diseases, pain, respiratory diseases, age-related diseases and amelioration of metabolism; dietary supplements and dietetic preparations adapted for medical purposes; plant and herb extracts for medical, pharmaceutical use and for use as food supplements

Goods & Services

(1) Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical substances for use as food ingredients; Curcuma longa L. and Boswellia serrata extracts for use in the manufacture of food supplements. (2) Pharmaceuticals for the treatment of gastrointestinal diseases, osteoarthritis, bone and joints diseases, pain, respiratory diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, osteoarthritis, bone and joints diseases, pain, respiratory diseases; dietary supplements and dietetic preparations for general health and well-being; Curcuma longa L. and Boswellia serrata extracts for medical, pharmaceutical use and for use as food supplements.

Goods & Services

Chemicals derived from botanical extracts for use in the preparation of pharmaceutical products, cosmetic products, nutritional supplements and foodstuffs

Abstract

The invention relates to compositions in the form of solid dispersions, comprising: a) curcumin or an extract containing it; b) coenzyme Q10; c) a phospholipid, and d) a pharmaceutically or nutraceutically acceptable carrier. The invention also relates to a process for the preparation of the compositions and the use of the compositions to prepare pharmaceutical or nutraceutical formulations for use in enhancing energy metabolism and the cognitive functions and improving the cardiovascular function and the quality of aging.

IPC Classes  ?

• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
• A23L 33/12 - Fatty acids or derivatives thereof
• A61K 31/12 - Ketones
• A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
• A61K 9/14 - Particulate form, e.g. powders

Abstract

Disclosed is a method for the identification of Vaccinium myrtillus in a botanical composition and a kit specifically designed for its implementation. The method is based on the detection, using PCR amplification, of nucleic acid fragments within a genomic region of Vaccinium myrtillus.

IPC Classes  ?

• C12Q 1/6895 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
• C12Q 1/686 - Polymerase chain reaction [PCR]

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Active chemical ingredients for use in the manufacture of nutritional supplements and dietetic preparations; Chemicals for use in the manufacture of pharmaceuticals, nutritional supplements and dietetic preparations Cosmetics Pharmaceutical products for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Pharmaceutical preparations and substances for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, central nervous system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome; Dietary and nutritional supplements; Plant and herb extracts for medicinal and pharmaceutical purposes and for the manufacture of dietary and nutritional supplements Custom manufacture of pharmaceuticals by pharmaceutical compounders

Goods & Services

Custom manufacture of pharmaceuticals by pharmaceutical compounders

Abstract

The present invention relates to a solid dispersion of Cabozantinib malate in a graft copolymer and the preparation process thereof.

IPC Classes  ?

• A61K 9/14 - Particulate form, e.g. powders
• A61K 31/00 - Medicinal preparations containing organic active ingredients

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations. Cosmetics. Pharmaceuticals; Pharmaceutical preparations and substances; Dietary supplements and dietetic preparations; Plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Abstract

The present invention relates to a composition comprising cannabidiol and at least two excipients, wherein at least one excipient is a lipid excipient and wherein at least one excipient is a hydrophilic excipient, and wherein the lipid excipient is present in an amount equal to or lower than 20% of the total weight of the composition; the invention also relates to the preparation process of the composition and to pharmaceutical or nutraceutical formulations containing it.

IPC Classes  ?

• A61K 9/10 - DispersionsEmulsions
• A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
• A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Goods & Services

Chemicals derived from botanical extracts for use in the preparation of pharmaceutical products, cosmetic products, nutritional supplements and foodstuffs

Abstract

1 is a —X—SH group.

IPC Classes  ?

• C07D 498/18 - Bridged systems
• C07D 498/12 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical substances for use as food ingredients. Pharmaceuticals; Pharmaceutical preparations and substances; Dietary supplements and dietetic preparations; Plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

Active chemical ingredients for production of foodstuffs, active chemical ingredients for the production of dietetic preparations; chemical preparations for the production of foodstuffs, chemicals for the production of dietetic preparations; plant extracts and herbs for use in the manufacture of dietary supplements and dietetic preparations. Dietary supplements and dietetic preparations; plant extracts and herbs used as dietary supplements and dietetic preparations.

Abstract

A process for the synthesis of Cannabidiol of formula (1): (1) is herein disclosed. The process comprises contacting a solution [solution (S1)] of (+)-p-mentha-diene-3-ol of formula (4) (4) or an ester thereof and olivetol of formula (3): (3) with a solution [solution (S2)] of a non-supported Lewis acid in a continuous flow reactor and treatment of the resulting mixture with a basic solution. The process offers the advantage that it can be conveniently carried out on an industrial scale while avoiding the formation of abnormal CBD and THC (Δ9-tetrahydrocannabinol). A process for the synthesis of Cannabidiol of formula (1): (1) is herein disclosed. The process comprises contacting a solution [solution (S1)] of (+)-p-mentha-diene-3-ol of formula (4) (4) or an ester thereof and olivetol of formula (3): (3) with a solution [solution (S2)] of a non-supported Lewis acid in a continuous flow reactor and treatment of the resulting mixture with a basic solution. The process offers the advantage that it can be conveniently carried out on an industrial scale while avoiding the formation of abnormal CBD and THC (Δ9-tetrahydrocannabinol).

IPC Classes  ?

• C07C 37/16 - Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by condensation involving hydroxy groups of phenols or alcohols or the ether or mineral ester group derived therefrom

Abstract

122O3O11Colchicaceae12323O3OO-demethylcolchicine 3 to colchicine 1 using an alkylating agent.

IPC Classes  ?

• C12P 7/02 - Preparation of oxygen-containing organic compounds containing a hydroxy group
• C12P 13/02 - Amides, e.g. chloramphenicol
• C12P 15/00 - Preparation of compounds containing at least three condensed carbocyclic rings
• C12P 19/56 - Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
• A61P 19/06 - Antigout agents, e.g. antihyperuricemic or uricosuric agents
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• C07H 15/248 - Colchicine radicals, e.g. colchicosides

Goods & Services

(1) Active chemical ingredients for production of foodstuffs, active chemical ingredients for the production of dietetic preparations; chemical preparations for the production of foodstuffs, chemicals for the production of dietetic preparations; plant extracts and herbs for use in the manufacture of dietary supplements and dietetic preparations. (2) Dietary supplements and dietetic preparations for general health and well-being; plant extracts and herbs used as dietary supplements and dietetic preparations for general health and well-being.

Goods & Services

Active chemical ingredients in the nature of additives for use in the production of foodstuffs, active chemical ingredients for use in the production of dietetic preparations; chemical preparations in the nature of additives for use in the production of foodstuffs, chemicals for use in the production of dietetic preparations; plant and herb extracts for use in the manufacture of dietary supplements and dietetic preparations Dietary supplements and dietetic preparations adapted for medical purposes; plant extracts and herb extracts used as dietary supplements and as dietetic preparations adapted for medical purposes

Goods & Services

Chemicals and botanical extracts for industrial use in the veterinary, pharmaceutical, cosmetic, food, nutritional supplement, and medical foods industries Cosmetics containing botanical extracts, not for medical purposes, namely, face creams, beauty gels, non-medicated ointments for the prevention and treatment of sunburn; pre-sun and after-sun bath products containing botanical extracts, namely, bath gels, bath lotions, bath milks; lipsticks

Goods & Services

Pharmaceutical preparations, namely, preparations for cardiovascular treatment, gastroenteric treatment, for the central nervous system; antibacterial substances for medical purposes; antitumoral drugs, namely, pharmaceutical preparations for suppressing tumors; veterinary preparations, namely, preparations for cardiovascular treatment, gastroenteric treatment, for the central nervous system; antibacteric, antitumoral drugs for livestock and domestic animal; dietetic foods adapted for medical use; nutritional supplements

Abstract

Disclosed is a process for the purification of staurosporine (1), which comprises salification of staurosporine (1) (Formula (1)) by treatment with a mineral acid to give a precipitated salt, isolation of the staurosporine (1) precipitated salt, treatment of the staurosporine (1) isolated salt with an organic base, and isolation of staurosporine (1). Also disclosed are novel polymorphic forms of the mono- and bis-hydrochloride salts of staurosporine (1).

IPC Classes  ?

• C07D 498/22 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemicals for use in the manufacture of cosmetics; botanical extracts for use in making cosmetics; chemical substances for use as food ingredients. Pharmaceuticals; pharmaceutical preparations and substances; dietary supplements and dietetic preparations; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Abstract

The present invention relates to a process for the preparation of Lenvatinib of formula (I) from 4-amino-3-chloro-phenol and 4-chloro-7-methoxyquinoline-6-carboxamide.

IPC Classes  ?

• C07D 215/233 - Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4

Abstract

Disclosed are compositions comprising grape seed extracts, in particular extracts with a proanthocyanidin content exceeding 95% by weight and a catechin and epicatechin content ? 5% and ? 15% by weight, which are useful to prevent or reduce the perception of stress symptoms, in particular the perception of stress among the male population.

IPC Classes  ?

• A61K 36/87 - Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine

Abstract

Disclosed are compositions comprising grape seed extracts, in particular extracts with a proanthocyanidin content exceeding 95% by weight and a catechin and epicatechin content ≥ 5% and ≤ 15% by weight, which are useful to prevent or reduce the perception of stress symptoms, in particular the perception of stress among the male population.

IPC Classes  ?

• A61K 36/87 - Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
• A61P 43/00 - Drugs for specific purposes, not provided for in groups

Goods & Services

(1) Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome; chemicals for use in the manufacture of cosmetics; botanical extracts for use in making cosmetics; chemical substances for use as food ingredients (2) Pharmaceuticals for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome; pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome; dietary supplements and dietetic preparations for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome; plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements, namely for the prevention and treatment of metabolic diseases and disorders, namely metabolic syndrome

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating metabolic diseases, namely, diabetes, hyperglycaemia, hypercholesterolaemia, metabolic syndrome, vascular diseases and inflammatory diseases; active chemical ingredients for use in the manufacture of dietary supplements and dietetic preparations adapted for medical purposes; chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; chemical additives for use in the manufacture of cosmetics; botanical extracts for use in making cosmetics; chemical substances for use as food ingredients, namely, berberine for use in the manufacture of food Pharmaceuticals, namely, hypoglycemic agents, hypocholesterolemic agents, agents for the treatment of vascular diseases and anti-inflammatory agents; pharmaceutical preparations and substances, namely, hypoglycemic agents, hypocholesterolemic agents, agents for the treatment of vascular diseases and anti-inflammatory agents; dietary supplements and dietetic preparations adapted for medical purposes; plant and herb extracts for medicinal and pharmaceutical purposes and for the preparation of food supplements

Abstract

Spilanthes oleracea) extract.

IPC Classes  ?

• A61K 36/28 - Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
• A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/12 - Ketones
• A61K 36/758 - Zanthoxylum, e.g. pricklyash
• A61K 36/9066 - Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
• A61K 36/9068 - Zingiber, e.g. garden ginger

Abstract

22n222n22222 group. The invention also provides novel intermediates useful for the preparation of Melphalan.

IPC Classes  ?

• C07C 227/20 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino acids or derivatives thereof, e.g. hydrolysis of carbamates
• C07C 229/36 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
• C07D 209/50 - Iso-indolesHydrogenated iso-indoles with oxygen and nitrogen atoms in positions 1 and 3

Goods & Services

Active chemical ingredients for production of foodstuffs, Active chemical ingredients for the production of dietetic preparations; Chemical preparations for the production of foodstuffs, Chemicals for the production of dietetic preparations. Dietary supplements and dietetic preparations; Plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

Active chemical ingredients for production of foodstuffs, Active chemical ingredients for the production of dietetic preparations; Chemical preparations for the production of foodstuffs, Chemicals for the production of dietetic preparations. Dietary supplements and dietetic preparations; Plant extracts and herbs for the preparation of dietary supplements and dietetic preparations.

Goods & Services

Chemicals used in industry, namely, active principles and extracts obtained from medicinal plants for use in pharmaceutical, cosmetic and health food industries Cosmetic creams, cosmetic oils, lotions for cosmetic purposes, hair shampoos and bath soaps for personal use containing active principles and extracts obtained from medicinal plants Pharmaceutical preparations containing extracts and active principles from medicinal plants for the treatment of disorders of the cardiovascular system, gastrointestinal and respiratory systems, for the immune and endocrine systems and for the treatment of viral diseases

Goods & Services

Medicinal plants extracts for pharmaceutical and medical use for the treatment of metabolic diseases, namely, diabetes and dislipidemy, and for body weight control

Abstract

The present invention relates to solid dispersions comprising a salt of ursolic acid with an alkali metal and a phospholipid and to oral dosage formulations containing them. The invention also relates to processes for preparing the solid dispersions and to the use of the solid dispersions and formulations for the prevention and/or treatment of a variety of pathological conditions in which hepatoprotective, antioxidant, anti-inflammatory, antiviral and cytotoxic activities are desired.

IPC Classes  ?

• A61K 9/107 - Emulsions
• A61K 9/14 - Particulate form, e.g. powders
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Abstract

The present invention relates to solid dispersions comprising a salt of ursolic acid with an alkali metal and a phospholipid and to oral dosage formulations containing them. The invention also relates to processes for preparing the solid dispersions and to the use of the solid dispersions and formulations for the prevention and/or treatment of a variety of pathological conditions in which hepatoprotective, antioxidant, anti-inflammatory, antiviral and cytotoxic activities are desired.

IPC Classes  ?

• A61K 9/107 - Emulsions
• A61K 9/14 - Particulate form, e.g. powders
• A61K 9/16 - AgglomeratesGranulatesMicrobeadlets

Goods & Services

Plant and herb extracts sold as components of cosmetics Medicinal plant extracts for pharmaceutical and medical use, namely, for the treatment of cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases and for the treatment of viral diseases

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemicals for use in the manufacture of cosmetics; Botanical extracts for use in making cosmetics; Chemical substances for use as food ingredients. Pharmaceuticals; Pharmaceutical preparations and substances; Dietary supplements and dietetic preparations; Plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Goods & Services

Active chemical ingredients for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemical preparations for use in the manufacture of pharmaceuticals, dietary supplements and dietetic preparations; Chemicals for use in the manufacture of cosmetics; Botanical extracts for use in making cosmetics; Chemical substances for use as food ingredients. Pharmaceuticals; Pharmaceutical preparations and substances; Dietary supplements and dietetic preparations; Plant and herb extracts for medical, pharmaceutical use and for the preparation of food supplements.

Abstract

An anhydrous, crystalline form of Cabazitaxel [Form (H-1)] is herein disclosed. Form H-1 shows a13C SS-NMR spectrum featuring one single polymorph and showing the same advantages as known form H with respect to known Form D in terms of stability to humidity and impurities A, B and C. A process for the obtainment of Form H-1 is also herein disclosed.

IPC Classes  ?

• C07D 305/14 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Abstract

Disclosed are compositions including berberine combined with pea proteins and one or more surfactants. Also disclosed are processes for the preparation of the compositions, and the formulations and uses thereof.

IPC Classes  ?

• A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
• A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
• A61K 36/752 - Citrus, e.g. lime, orange or lemon
• A61K 36/87 - Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
• A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters